SCHEMBL7583928

SCHEMBL7583928

O=C(O)C(Nc1ccc(Cl)cc1Cl)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.51
TAS1R1 Q7RTX1 2/20 0.51
CA1 P00915 2/20 0.50
CA14 Q9ULX7 1/20 0.50
KDM4E B2RXH2 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
ALDH1A1 P00352 4/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
EGFR P00533 1/20 0.47
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
HTT P42858 1/20 0.44
CRHR1 P34998 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7577574 0.88 MEN1 (0.48) TAS1R3TAS1R1CA1NPSR1ALDH1A1
SCHEMBL7577550 0.85 PPARG (0.51) TAS1R3TAS1R1KDM4EALDH1A1MAPT
SCHEMBL6244215 0.83 KCNQ2 (0.53) CA1KDM4ENPSR1ALDH1A1LMNA
SCHEMBL7575575 0.83 KCNMA1 (0.54) KDM4ENPSR1LMNAMAPTNPC1
SCHEMBL7574221 0.81 ALDH1A1 (0.44) TAS1R3TAS1R1CA1KDM4EALDH1A1
SCHEMBL3810329 0.80 CA1 (0.46) TAS1R3TAS1R1CA1CA14KDM4E
SCHEMBL7573328 0.79 ALDH1A1 (0.63) KDM4ENPSR1ALDH1A1LMNAMAPT
SCHEMBL7582482 0.77 CA1 (0.46) CA1KDM4EALDH1A1MAPTMEN1
SCHEMBL1696047 0.77 MDM2 (0.48) CA1KDM4EALDH1A1LMNAGAA
SCHEMBL2639604 0.76 NPC1 (0.54) KDM4ENPSR1ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242069-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2002-09-25 EP disclosed
WO-2001003684-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2001-01-18 WO disclosed